Published 2021
| Version v1
Publication
Effects of the GPR17 antagonist montelukast on oligodendrocyte dysfunction and disease outcome in the SOD1G93A mouse model of ALS
Additional details
- URL
- http://hdl.handle.net/11567/1055272
- URN
- urn:oai:iris.unige.it:11567/1055272
- Origin repository
- UNIGE